Z-Val-OHCAS# 1149-26-4 |
- Q-VD-OPh hydrate
Catalog No.:BCC1125
CAS No.:1135695-98-5
- Cisplatin
Catalog No.:BCN1552
CAS No.:14283-03-5
- Z-WEHD-FMK
Catalog No.:BCC1139
CAS No.:210345-00-9
- Z-LEHD-FMK
Catalog No.:BCC5117
CAS No.:210345-04-3
- AZ 10417808
Catalog No.:BCC2356
CAS No.:331645-84-2
- Apoptosis Activator 2
Catalog No.:BCC2099
CAS No.:79183-19-0
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1149-26-4 | SDF | Download SDF |
PubChem ID | 6925692 | Appearance | Powder |
Formula | C13H17NO4 | M.Wt | 251.3 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2R)-3-methyl-2-(phenylmethoxycarbonylamino)butanoate | ||
SMILES | CC(C)C(C(=O)[O-])NC(=O)OCC1=CC=CC=C1 | ||
Standard InChIKey | CANZBRDGRHNSGZ-LLVKDONJSA-M | ||
Standard InChI | InChI=1S/C13H17NO4/c1-9(2)11(12(15)16)14-13(17)18-8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3,(H,14,17)(H,15,16)/p-1/t11-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Z-Val-OH Dilution Calculator
Z-Val-OH Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.9793 mL | 19.8965 mL | 39.7931 mL | 79.5862 mL | 99.4827 mL |
5 mM | 0.7959 mL | 3.9793 mL | 7.9586 mL | 15.9172 mL | 19.8965 mL |
10 mM | 0.3979 mL | 1.9897 mL | 3.9793 mL | 7.9586 mL | 9.9483 mL |
50 mM | 0.0796 mL | 0.3979 mL | 0.7959 mL | 1.5917 mL | 1.9897 mL |
100 mM | 0.0398 mL | 0.199 mL | 0.3979 mL | 0.7959 mL | 0.9948 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Z-Val-OH
- Trabectedin
Catalog No.:BCC2012
CAS No.:114899-77-3
- Boc-Phe(3-Cl)-OH
Catalog No.:BCC2640
CAS No.:114873-03-9
- Boc-Phe(2-F)-OH
Catalog No.:BCC3223
CAS No.:114873-00-6
- ST-836
Catalog No.:BCC1968
CAS No.:1148156-63-1
- Z-Pro-OH
Catalog No.:BCC2754
CAS No.:1148-11-4
- Losartan
Catalog No.:BCC4090
CAS No.:114798-26-4
- 4-Bromomethyl-2-cyanobiphenyl
Catalog No.:BCC8702
CAS No.:114772-54-2
- tert-Butyl4'-(bromomethyl)biphenyl-2-carboxylate
Catalog No.:BCC9164
CAS No.:114772-40-6
- Methyl 4'-bromomethyl biphenyl-2-carboxylate
Catalog No.:BCC9039
CAS No.:114772-38-2
- Methyl 4'-methylbiphenyl-2-carboxylate
Catalog No.:BCC9040
CAS No.:114772-34-8
- 2-(2-Aminobenzoyl)-benzoic acid
Catalog No.:BCC8476
CAS No.:1147-43-9
- Columbianetin
Catalog No.:BCN8502
CAS No.:1147-29-1
- Ciwujianoside B
Catalog No.:BCN1082
CAS No.:114902-16-8
- Ciwujianoside E
Catalog No.:BCN3505
CAS No.:114912-36-6
- Docetaxel intermediate
Catalog No.:BCN8360
CAS No.:114915-14-9
- 2-Chloro-1-(5'-(prop-1-ynyl)-2,2'-bithiophen-5-yl)ethanol
Catalog No.:BCN1614
CAS No.:114916-00-6
- N1,N10-Bis(p-coumaroyl)spermidine
Catalog No.:BCN6027
CAS No.:114916-05-1
- XL-888
Catalog No.:BCC2339
CAS No.:1149705-71-4
- Docetaxel
Catalog No.:BCN5342
CAS No.:114977-28-5
- Bromophenol Blue
Catalog No.:BCC8029
CAS No.:115-39-9
- Azacyclonol
Catalog No.:BCC4761
CAS No.:115-46-8
- Sinomenine
Catalog No.:BCN6265
CAS No.:115-53-7
- Ambenonium dichloride
Catalog No.:BCC6630
CAS No.:115-79-7
- Linalyl Acetate
Catalog No.:BCC8200
CAS No.:115-95-7
Solution synthesis of the glyco-hexapeptide sequence of the human oncofetal fibronectin defined by monoclonal antibody FDC-6.[Pubmed:1724973]
Int J Pept Protein Res. 1991 Nov;38(5):417-27.
The glyco-hexapeptide sequence H-Val-(GalNAc-alpha)Thr-His-Pro-Gly-Tyr-OH, was synthesized in solution by the segment condensation procedure and the stepwise procedure. A peracetylated, O-galactosaminyl threonine derivative was used for incorporating the glycosylated amino acid residue into the peptide chain. A consistent racemization occurred during the acylation of H-His-Pro-Gly-Tyr(Bzl)-OBzl with Z-Val-[GalNAc(Ac)3-alpha]Thr-OH by the BOP-HOBt procedure and the D-allothreonine containing glyco-hexapeptide was isolated in about 20% yield. Stepwise elongation of the C-terminal tetrapeptide with Fmoc-[GalNAc(Ac)3-alpha]Thr-OH and Z-Val-OH, in the presence of the same coupling reagents, yielded the L-threonine containing diastereoisomer without detectable racemization. A side product, the Nim-ethoxycarbonylated hexapeptide derivative, formed during the EEDQ-mediated condensation of Fmoc-[GalNAc(Ac)3-alpha]Thr-OH with the C-terminal tetrapeptide, was isolated and characterized. Preliminary studies showed that the synthetic glycohexapeptide is a good competitive inhibitor of the binding of the FDC-6 monoclonal antibody to the oncofetal fibronectin, supporting the idea that it should represent the minimum essential structure required for the FDC-6 activity.